UDC and LCC Partners in Cancer Prevention and Control

描述(由申请人提供) 哥伦比亚特区大学(UDC)和隆巴迪癌症中心(LCC)正在提议建立一个由U56资助的规划伙伴关系，该伙伴关系将建立在他们目前资助的P20伙伴关系的成功基础上。U56资助的伙伴关系将专门专注于癌症预防和控制。这对哥伦比亚特区(DC)来说是一个高度相关的焦点，该地区的癌症死亡率在全国名列前茅。具体目标是：(1)建立规划和评估核心，以确定优先事项、评估进展和决定成功；(2)建立发展核心，从4个试点项目和新教师招聘开始；(3)建立LCC和UDC联合教授的癌症生物学、预防和控制方面的UDC硕士课程。这种伙伴关系的目标是使研究人员能够发展互惠互利的合作关系，值得获得新的同行审查资金。因此，这个U56机制专注于获得试点数据，使我们能够测试未来的假设，而不是回答当前的研究问题，这些问题将导致发表论文。在头两年，试点项目的重点是获得R01‘S等赠款所需的数据结构，而预计在接下来的几年里，我们将专注于获得U54合作伙伴赠款的数据。这四个试点项目涵盖了癌症控制的范围。这些措施包括：1)一个涉及低收入孕妇的营养项目；2)通过包装烟草行业文件中针对非裔美国人的数据，利用反营销技术预防吸烟；3)增加少数群体参加临床试验的人数；4)确定将对少数群体的姑息治疗纳入医学院课程的方法。我们还将建立一个联合开展的癌症生物学、预防和控制硕士课程，强调基础科学和癌症控制需要更有效的癌症控制研究，并鼓励少数族裔学生追求研究事业。这个U56伙伴关系是可行的，结果是可以实现的，因为有了P20的资助，我们发现我们的教职员工可以在研究和教学项目上合作。我们已经确定，在癌症预防和控制领域，每个机构的优势和局限性是最具互补性的。每个机构都以书面形式表示承诺，以确保伙伴关系的成功。

DESCRIPTION (provided by applicant) The University of the District of Columbia (UDC) and the Lombardi Cancer Center (LCC) are proposing to establish a planning U56 funded Partnership that will build upon their successes in a currently funded P20 Partnership. The U56-funded Partnership will focus exclusively on Cancer Prevention and Control. This is a highly relevant focus for the District of Columbia (DC), which has among the higher cancer death rates in the nation. The specific aims are: (1) to establish a Planning and Evaluation Core that will identify priorities, evaluate progress and determine success; (2) to establish a Developmental Core that will begin with 4 pilot projects and new faculty recruits and; (3) to establish a LCC and UDC jointly taught UDC masters program in Cancer Biology, Prevention and Control. The goal of this partnership is to allow the investigators to develop mutually beneficial collaborations worthy of new peer-reviewed funding. Thus, this U56 mechanism is focused on obtaining pilot data that will allow us to test future hypotheses, rather than answer current research questions that would lead to publications. In the first two years, the pilot projects are focused on the structure of data needed to obtain grants such as R01's, while it is anticipated that in the later years we will focus on data to obtain a U54 Partnership grant. The four pilot projects span the range of cancer control. These include: 1) a nutrition project involving low-income pregnant women; 2) use of counter-marketing techniques for prevention of cigarette smoking by packaging data from tobacco industry documents targeting African Americans; 3) enhancing enrollment for minorities in clinical trials, and; 4) identifying methods to integrate palliative care for minorities in medical school curricula. We also will establish a jointly conducted masters program in Cancer Biology, Prevention and Control, emphasizing the need for basis sciences and cancer control for more effective cancer control research, and stimulating minority students to pursue research careers. This U56 Partnership is feasible and the outcomes are achievable because with the P20 funding we have found that our faculty can work together on both research and teaching projects. We have identified that the strengths and limitations of each institution are most complementary in the area of cancer prevention and control. Each institution has expressed in writing a commitment to insure the success of the Partnership.